Neurothera Labs

Neurothera Labs EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurothera Labs (NTLX.V) as of Nov 18, 2026 is -5.84 M CAD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -248,179.11 CAD — a change of 2,253.61% (lower).

EBITDA

-5.84 MCAD

YoY

2,253.61%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurothera Labs is 2026 -5.84 M CAD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurothera Labs was 2025 -248,179.11 CAD. It decreases by 2,253.61% lower compared to the previous year.

The Neurothera Labs EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2022
-149,869.00 CAD
Jan 1, 2023
-79,779.00 CAD
Jan 1, 2024
-109,937.85 CAD
Jan 1, 2025
-248,179.11 CAD
Jan 1, 2026
-5.84 M CAD
The Neurothera Labs EBITDA history
YEAREBITDAYoY
-5.84 MCAD+2,253.61%
-248,179.11CAD+125.74%
-109,937.85CAD+37.80%
-79,779.00CAD-46.77%
-149,869.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neurothera Labs Stock analysis

What does Neurothera Labs do? Miza III Ventures, Inc. operates as a capital pool company with no assets or operations. The company identifies and evaluates potential assets or businesses for a qualifying transaction but has not commenced operations. It generates no revenue and has no business activities. The firm does not engage in any commercial activities or generate income. Miza III Ventures, Inc. is a capital pool company focused on identifying and evaluating assets for a qualifying transaction. The company has no assets, no operations, and no revenue. It is not engaged in any business activities and has not started any operations. The company's business model revolves around the potential completion of a qualifying transaction. However, it has not yet identified any assets or businesses for evaluation. Miza III Ventures, Inc. remains inactive with no operational activities or revenue streams. Neurothera Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurothera Labs stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurothera Labs is -5.84 M CAD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurothera Labs changed from -248,179.11 CAD to -5.84 M CAD, representing a 2,253.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Neurothera Labs since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Neurothera Labs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Neurothera Labs

All Key Metrics — Neurothera Labs